152 related articles for article (PubMed ID: 36843435)
1. Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States.
Wong RJ; Rupp L; Lu M; Yang Z; Daida YG; Schmidt M; Boscarino JA; Gordon SC; Chitnis AS
J Viral Hepat; 2023 Jun; 30(6):512-519. PubMed ID: 36843435
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United States.
Wong RJ; Kaufman HW; Niles JK; Meyer WA; Chitnis AS
J Public Health Manag Pract; 2022 Sep-Oct 01; 28(5):452-462. PubMed ID: 35867500
[TBL] [Abstract][Full Text] [Related]
3. Safety of secukinumab in the treatment of patients with axial spondyloarthritis and concurrent hepatitis B virus infection or latent tuberculosis infection.
Liu S; He Z; Wu W; Jin H; Cui Y
Clin Rheumatol; 2023 Sep; 42(9):2369-2376. PubMed ID: 37219751
[TBL] [Abstract][Full Text] [Related]
4. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis.
Chou C; Veracruz N; Chitnis AS; Wong RJ
J Viral Hepat; 2022 Dec; 29(12):1107-1114. PubMed ID: 36138556
[TBL] [Abstract][Full Text] [Related]
5. Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis and Hepatitis B Virus in an Integrated Healthcare System - California, 2008-2019.
Malden DE; Wong RJ; Chitnis AS; Im TM; Tartof SY
Am J Med; 2024 Mar; 137(3):258-265.e3. PubMed ID: 38000687
[TBL] [Abstract][Full Text] [Related]
6. Viral hepatitis prevalence in patients with active and latent tuberculosis.
Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis.
Chen J; Hubbard A; Bagley L; Shiau R; Wong RJ; Chitnis AS
Dig Dis Sci; 2022 Jun; 67(6):2646-2654. PubMed ID: 34056681
[TBL] [Abstract][Full Text] [Related]
8. Screening Practices for Latent Tuberculosis Infection in Clinical Trials Evaluating Treatments for Chronic Hepatitis B Virus Infection.
Le S; Martin B; Chitnis AS; Wong RJ
J Immigr Minor Health; 2022 Dec; 24(6):1594-1598. PubMed ID: 35429265
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States.
Chitnis AS; Cheung R; Gish RG; Wong RJ
J Immigr Minor Health; 2021 Dec; 23(6):1267-1279. PubMed ID: 34160726
[TBL] [Abstract][Full Text] [Related]
10. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
Tyson GL; Kramer JR; Duan Z; Davila JA; Richardson PA; El-Serag HB
Hepatology; 2013 Aug; 58(2):538-45. PubMed ID: 23505059
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B surface antigen and hepatitis B core antibody among adults with latent tuberculosis infection.
Hubbard A; Hirode G; Chitnis A; Wong R
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e610-e614. PubMed ID: 35048652
[TBL] [Abstract][Full Text] [Related]
13. The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies.
Zheng J; Guo MH; Peng HW; Cai XL; Wu YL; Peng XE
Epidemiol Infect; 2020 Nov; 148():e290. PubMed ID: 33222713
[TBL] [Abstract][Full Text] [Related]
14. Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn's Disease on Ustekinumab: A Nationwide Real-World Study.
Liu R; Li Z; Ye L; Hu J; Tang J; Chen B; Chen X; Tan B; Gu Y; Xie C; Ouyang C; Song X; Li F; Fan Y; Ren H; Zhu L; Chen M; Jiang W; Cao Q
Inflamm Bowel Dis; 2024 Jan; 30(1):45-52. PubMed ID: 36880432
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of Latent Tuberculosis Infection in the United States.
Mancuso JD; Diffenderfer JM; Ghassemieh BJ; Horne DJ; Kao TC
Am J Respir Crit Care Med; 2016 Aug; 194(4):501-9. PubMed ID: 26866439
[TBL] [Abstract][Full Text] [Related]
17. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F
J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539
[TBL] [Abstract][Full Text] [Related]
19. The role of chronic viral hepatitis on tuberculosis treatment interruption.
Chua AP; Lim LK; Gan SH; Chee CB; Wang YT
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1486-1494. PubMed ID: 30606322
[TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment.
Trigo C; do Brasil PE; Costa MJ; de Castro L
J Viral Hepat; 2016 Dec; 23(12):1027-1035. PubMed ID: 27624908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
